Dimethyltryptamine (DMT): Prevalence, user characteristics and abuse liability in a large global sample
Journal of Psychopharmacology November 27, 2013 Adam Winstock, Stephen J. Kaar, Rohan Borschmann 101 citations
Based on a large anonymous online survey of 22,289 people, lifetime use of the potent hallucinogen DMT was 8.9% and past-year use was 5.0%. Among 472 respondents who had recently tried DMT for the first time, the drug produced a strong, intense, short-lived psychedelic high with relatively few negative effects or comedown compared to psilocybin, LSD, and ketamine. DMT had a larger proportion of new users (24%) than the other substances, suggesting its popularity may increase. The authors conclude that DMT has a very desirable effect profile indicating high abuse liability, possibly offset by a low urge to use more.